Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acupuncture plus tolterodine versus tolterodine alone for adult women with overactive bladder
ChiCTR-TRC-14005243Phase 4Completed
- Sponsor
- Dujiangyan People's Hospital
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tolterodine in overactive bladder (OAB) (2 arms), sponsored by Dujiangyan People's Hospital. Primary endpoints: Urgency episodes per 24 hours, Urgency incontinence episodes per 24 hours and 3 more. Started Sep 2014; status: completed.
02
Drugs
tolterodine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on ChiCTR-TRC-14005243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14005243.